The Maxwell® CSC RNA FFPE Kit is intended for use, in combination with the Maxwell® CSC Instrument and the Maxwell® CSC RNA FFPE purification method, as an in vitro diagnostic (IVD) medical device to perform automated isolation of RNA from human breast, lung and colon FFPE (formalin-fixed, paraffin-embedded) tissue samples. The purified RNA is suitable for use in amplification-based in vitro diagnostic assays. The kit uses predispensed reagent cartridges to maximize simplicity and convenience and reduce variability.
The Maxwell® CSC Instrument is preprogrammed with the purification method and can process up to 16 samples in under 50 minutes. The purified RNA can be used directly in a variety of amplification-based downstream applications, such as RT-PCR.
Product is currently only available in Austria, Belgium, Canada, China, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Latvia, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom and United States.